KO-MED Centra Kliniczne

What KO-MED Centra Kliniczne does

KO-MED Centra Kliniczne is a Poland-based, privately held operator of a network of clinical trial research centers. Founded in 1999 by Marek Konieczny, who continues to serve as chairman of the board, the company is headquartered in Pulawy and conducts clinical research projects across multiple sites throughout Poland, serving the pharmaceutical and biotech industry as its primary customer segment. Its functional role is that of a multi-site clinical trial operator (site network) rather than a full-service contract research organization, providing the physical infrastructure, investigators, and patient-recruitment footprint that sponsors rely on to execute late-stage clinical studies within the Polish healthcare system.

The company's service offering, based on available data, is concentrated on the operational conduct of clinical trials and supporting research for new drugs, therapies, and medical devices — no distinct branded product lines, technology platforms, or digital tools are identified in the source material. Headcount is reported at 101–250 employees, consistent with a mid-sized multi-site operator. KO-MED's geographic scope is explicitly national (Poland), and its marketing, distribution, and pricing details are not disclosed in the available data. No named sponsor customers, partnerships, certifications, patents, or regulatory actions are documented in the input.

Commercially, the company operates as a fee-for-service site network generating revenue from pharmaceutical and biotech sponsors that contract its centers for protocol execution, patient recruitment, and clinical data collection. However, the input contains no disclosed revenue, funding history, ownership structure, or financial detail of any kind, and no information on senior management beyond the founder/chairman. As a result, the financial scale, growth dynamics, and competitive positioning of the business cannot be quantified from the source data — only the structural facts of a 25-year-old, mid-sized, domestically focused Polish clinical site network are supported.

Name

KO-MED Centra Kliniczne

Website

https://komed-ck.pl

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

KO-MED Centra Kliniczne is a Poland-based network of clinical research centers, founded in 1999, that conducts clinical trials and supporting research for pharmaceutical and biotech sponsors across Poland.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)

Keywords

• Clinical research services
• Clinical trial network
• Contract research organization
• Medical device trials
• Pharmaceutical research sites

Headquarters

HQ city

Pulawy

HQ country

Poland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Core offering

KO-MED Centra Kliniczne operates a network of modern research centers across Poland that conduct clinical research projects for pharmaceutical, biotechnology, and medical device sponsors. The company's service is the clinical trial itself—patient recruitment, study execution, and research site operations across multiple Polish locations. The fundamental activity is operating physical clinical research sites and managing clinical projects within Poland rather than developing a software or digital platform.

Product overview

KO-MED Centra Kliniczne is a network of modern research centers conducting clinical research projects across Poland. Based on the limited source data available, no specific named products, modules, or distinct service offerings were identified in the provided content.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical research projects across a network of Polish research centers End-to-end clinical research project execution delivered through KO-MED's network of modern research centers in Poland, supporting pharmaceutical, biotechnology, and medical device sponsors with site-based clinical trial operations across the country.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Broad incumbents

• Parexel International: Global CRO providing biopharmaceutical clinical trial services including site operations. Comparable to KO-MED in clinical research service delivery for pharma sponsors, though at much larger scale.
• Syneos Health: Global clinical and commercial solutions provider including site management and clinical trial services. Comparable in delivering clinical research services to pharma/biotech sponsors alongside site operations.
• Medpace: Mid-sized global CRO with full-service clinical trial delivery including site management. Comparable to KO-MED in clinical-trial execution for pharma/biotech sponsors.
• IQVIA: World's largest clinical research services provider with global site network and full-service CRO capabilities. Comparable as a clinical trial site/services competitor serving the same pharma sponsor base as KO-MED.
• ICON plc: Global CRO running site operations, monitoring, and full-service clinical research across all major regions. Comparable to KO-MED as a clinical-trial service provider to pharma/biotech sponsors, though operating at much broader scale.

Direct peers

• Velocity Clinical Research: Multi-site clinical research site network operating dedicated research centers across the US and internationally. Closely comparable to KO-MED's operating model of networked modern research centers running clinical trials.
• KCR: Polish-headquartered clinical research organization providing CRO and site-support services across the CEE region. Comparable to KO-MED as a Poland-rooted clinical research operator targeting pharmaceutical/biotech sponsors.
• CenExel: US-focused clinical research site network with multiple dedicated research centers. Comparable to KO-MED as a network model of dedicated research centers running trials for pharma sponsors.
• Clinmark: Polish/EEA clinical research and pharma services provider. Comparable to KO-MED in operating clinical research infrastructure for pharma sponsors within the Polish and broader CEE market.

Regional players

• SMO/contract research site operators in Poland (e.g., NZOZ Pró-Familia, clinical site networks): Polish clinical/diagnostic site operators that also participate in clinical trials in Poland. Comparable to KO-MED as Polish regional site providers competing for the same sponsor-placed studies domestically.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/ko-med-centra-kliniczne

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KO-MED Centra Kliniczne